Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa

Critical Care Medicine

Volumn 30, Issue 3, 2002, Pages 521-528

  Hauser, Alan R ^a   Cobb, Enesha ^b   Bodí, Maria ^c   Mariscal, Dolors ^d   Vallés, Jordi ^d   Engel, Joanne N ^b   Rello, Jordi ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d HOSPITAL DE SABADELL   (Spain)

Author keywords

Bacterial infections; Bacterial toxins; Hospital mortality; Pneumonia; Pseudomonas aeruginosa; Treatment outcome

Indexed keywords

BACTERIAL TOXIN; PROTEIN;

ARTICLE; ASSISTED VENTILATION; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BRONCHOSCOPY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; OUTCOMES RESEARCH; PATHOGENICITY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

EID: 0036191393     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200203000-00005     Document Type: Article

References (68)

1. National Nosocomial Infections Surveillance report, data summary from October 1986-April 1996, issued May 1996
2. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia
3. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa
4. Survival in patients with nosocomial pneumonia: Impact of the severity of illness and the etiologic agent
5. Nosocomial pneumonia in patients receiving continuous mechanical ventilation
6. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria
7. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
8. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury
9. The influence of miniBAL cultures on patient outcomes
10. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation
11. Nosocomial pneumonia. A multivariate analysis of risk and prognosis
12. The effect of late-onset ventilator-associated pneumonia in determining patient mortality
13. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
14. The value of routine microbial investigation in ventilator-associated pneumonia
15. Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: Adenosine diphosphate ribosylation of elongation factor 2
16. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II
17. Evaluation of Pseudomonas aeruginosa Exotoxin A and Elastase as virulence factors in acute lung infection
18. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats
19. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors
20. Pseudomonas aeruginosa elastase and elastolysis revisited: Recent developments
21. Alveolar epithelial injury and pleural empyema in acute Pseudomonas aeruginosa pneumonia in anesthetized rabbits
22. Assessment of elastase as a Pseudomonas aeruginosa virulence factor in experimental lung infection in mink
23. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection
24. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites
25. In vivo studies on protease and elastase from Pseudomonas aeruginosa
26. Genetic and biochemical analyses of a eukaryotic-like phospholipase D of Pseudomonas aeruginosa suggest horizontal acquisition and a role for persistence in a chronic pulmonary infection model
27. Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice
28. The exoenzyme S regulon of Pseudomonas aeruginosa
29. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
30. Exoproduct secretions of P. aeruginosa strains influence severity of alveolar epithelial injury
31. A type I cell-specific protein is a biochemical marker of epithelial injury in a rat model of pneumonia
32. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
33. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
34. PepA a novel secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence
35. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments
36. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases
37. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins
38. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells
39. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras
40. Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S
41. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells
42. ADP-ribosylation of oncogenic Ras proteins by Pseudomonas aeruginosa exoenzyme S in vivo
43. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells
44. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S
45. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages
46. Pseudomonas aeruginosa ExoT is a Rho GTPaseactivating protein
47. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system
48. Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system
49. Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells
50. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
51. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread
52. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: Relapse or reinfection?
53. Methodology for clinical investigation of ventilator-associated pneumonia: Epidemiology and therapeutic investigation
54. Identification of Pseudomonas aeruginosa genes required for epithelial cell injury
55. Acetylornithinase of Escherichia coli partial purification and some properties
56. Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S
57. A simple and rapid method for the preparation of Gram-negative bacterial genomic DNA
58. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
59. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections
60. Exoenzyme S: An ADP-ribosyl transferase produced by Pseudomonas aeruginosa
61. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III secretion pathway
62. Cloning and sequence analysis of a trans-regulatory locus required for Exoenzyme S synthesis in Pseudomonas aeruginosa
63. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates
64. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
65. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections
66. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa